# Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome

> **NCT07715760** · NA · NOT_YET_RECRUITING · sponsor: **Xiyuan Hospital of China Academy of Chinese Medical Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Functional Dyspepsia
- Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DRUG:** Hewei Anchang Formula Granules
- **DRUG:** Hewei Anchang Formula Matching Placebo Granules

## Key facts

- **NCT ID:** NCT07715760
- **Lead sponsor:** Xiyuan Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-01-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-07-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07715760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07715760, "Efficacy and Mechanistic Evaluation of Hewei Anchang Formula for Overlapping Gastrointestinal Symptoms in Patients With Coexisting Functional Dyspepsia and Diarrhea-Predominant Irritable Bowel Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07715760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*